Navigation Links
Oncolytics Biotech(R) Inc. Completes Patient Enrollment in Phase I Portion of U.S. Phase I/II Recurrent Malignant Gliomas Clinical Trial
Date:4/23/2010

nation REOLYSIN clinical trial for patients with recurrent malignant gliomas, and the Company's belief as to the potential of REOLYSIN as a cancer therapeutic, involve known and unknown risks and uncertainties, which could cause the Company's actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, among others, the availability of funds and resources to pursue research and development projects, the efficacy of REOLYSIN as a cancer treatment, the tolerability of REOLYSIN outside a controlled test, the success and timely completion of clinical studies and trials, the Company's ability to successfully commercialize REOLYSIN, uncertainties related to the research and development of pharmaceuticals and uncertainties related to the regulatory process. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned against placing undue reliance on forward-looking statements. The Company does not undertake to update these forward-looking statements, except as required by applicable laws.


'/>"/>
SOURCE Oncolytics Biotech Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Oncolytics Biotech(R) Inc. Receives Approval from the U.K. MHRA to Conduct Phase 3 Trial for REOLYSIN(R) in Head and Neck Cancers
2. Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development
3. Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters Over-Allotment Option
4. Oncolytics Biotech(R) Inc. Announces Unit Offering
5. Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase I/II Trial Results in Advanced Solid Cancers with a Focus on the Head and Neck at the AACR-NCI-EORTC Meeting
6. Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting
7. Oncolytics(R) Biotech Inc. Announces Issuance of 33rd U.S. Patent
8. Media Advisory - Oncolytics Biotech Inc. to Present at BIO Investor Forum 2009
9. Oncolytics Biotech(R) Inc. Announces Investment in Private Biotechnology Company
10. Media Advisory - Oncolytics Biotech(R) Inc. to Present at BioPartnering Europe
11. Oncolytics Biotech(R) Inc. Accelerates Warrant Expiry Date
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... YORK , May 21, 2015  Susan ... Research (FPWR), a nonprofit organization dedicated to supporting ... Prader-Willi syndrome (PWS), announced today that FPWR has ... and Irina Shaulov contributed $1 million ... clinical initiatives.  ...
(Date:5/21/2015)... , May 21, 2015 Imagine ... feelings - and those of others. Being able to ... Analyze and read people to anticipate their thoughts and ... deepest emotions and feelings to create unique abstract paintings ... responsive games. Get inside a first-person-shooter as it creates ...
(Date:5/21/2015)... ARIZ. (PRWEB) May 21, 2015 As ... Webb Medical Center (BDWMC), Sun Health Foundation funded a ... center’s new inpatient pharmacy with the most up-to-date features ... open June 2. The pharmacy's 45 staff members will ... larger 4,895-square-foot space in the coming days. , ...
(Date:5/21/2015)... King of Prussia, PA (PRWEB) May 21, 2015 ... that Julia O’Neill has joined the firm as senior ... more than 30 years of experience in the management ... the vaccines, biologics, pharmaceutical and chemical industries. , “We’re ... enhance our longstanding capabilities in data analytics,” said Dr. ...
Breaking Biology Technology:The Foundation for Prader-Willi Research Receives $1M Contribution in Support of Clinical Initiatives 25 Days to Meet ARGUS - The World's First Contactless Emotions Scanner 2Sun Health Foundation Provides $3.25M to Expand, Relocate Banner Del E. Webb Medical Center Pharmacy 2Sun Health Foundation Provides $3.25M to Expand, Relocate Banner Del E. Webb Medical Center Pharmacy 3Julia O’Neill Joins Tunnell Consulting’s Operational and Process Improvement Practice 2
... Thomas Edison invented the electric light, the central power ... to extract low-grade iron ore from sand cost him millions ... 1800s. , ,Steve Jobs was fired by Apple Computers, the ... of the Segway Human Transporter and holder of 150 patents, ...
... can the cables as we move deeper into our highly ... mobility, we are nowhere without energy to power the laptops, ... has turned the average business traveler into a Socket Scout, ... and coffee houses. Indeed, Im usually the last person to ...
... Commerce (Commerce) has qualified five small businesses for investor ... Fund Tax Credit Programs. , ,"By encouraging investors through ... helping to turn these great ideas into viable, job-creating ... Investor and Venture Fund Tax Credit Programs offer Wisconsin ...
Cached Biology Technology:Embracing failure is a necessary step for successful entrepreneurs 2Embracing failure is a necessary step for successful entrepreneurs 3Power for the people 2Five technology companies qualify for investor tax credits 2
(Date:4/14/2015)... 14, 2015  HYPR Corp. today announced it ... ) Alliance tm , an industry consortium transforming ... to share technology and collaborate to deliver open ... more secure and private, and easier to use. ... that protects sensitive user information and eliminates the ...
(Date:4/10/2015)... , April 10, 2015 Research ... of the "Security Competitive Profiles - NEC" ... , NEC will continue to supply a ... the market, with a company focus on the development ... Winning opportunities in the Asia-Pacific ...
(Date:4/2/2015)... , April 2, 2015 ... DERMALOG by far outperforms the strongest competitors, showing ... high accuracy, the system is capable of a ... speed proves up to be ten times faster ... its runner-up performance.      (Photo: ...
Breaking Biology News(10 mins):HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3NEC Security Competitive Profile 2015 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3
... day die from breast cancer in the United States. ... taking hormone replacement therapy to avoid the effects of ... Hyder may lead to treatments for breast cancers associated ... international team, found that hormone-therapy-related breast cancer cells have ...
... extensive joint research project among two American Indian tribes ... A. Fulton Schools of Engineering at Arizona State University ... the Phoenix Metropolitan area has received a national environmental ... was awarded a 2013 National Environmental Excellence Award by ...
... new study raises concerns about possible health impacts of very ... international aid agencies are promoting to replace open-fire cooking in ... Science & Technology . Brian Just and colleagues ... on stoves or open fires that burn wood, animal dung ...
Cached Biology News:Joint air toxics research project among tribes, agencies recognized for partnership 2Joint air toxics research project among tribes, agencies recognized for partnership 3
... Dog Serum-Mixed Breed • Dog serum is collected ... one year of age Available Anticoagulants: ... (Na) N-06: K2EDTA N-08: ... N-03: Alsevers N-05: ACD ...
MOUSE ANTI BOVINE TROPONIN I...
NORMAL DONOR DONKEY SERUM...
This BioSolution package is excellent for doing fluorescence thermal melt experiments on nucleic acids, studies involving biomolecular interactions, protein folding experiments, and more!...
Biology Products: